Entry |
|
Name |
Sodelglitazar (USAN) |
Formula |
C23H21F4NO3S2
|
Exact mass |
499.0899
|
Mol weight |
499.54
|
Structure |
|
Simcomp |
|
Class |
Antidiabetic agent
DG01685 Insulin sensitizer
DG01795 PPAR gamma agonist
DG01732 Non-thiazolidinedione type PPAR agonist
|
Efficacy |
Antidiabetic |
Comment |
Treatment of type 2 diabetes
|
Target |
|
Pathway |
|
Interaction |
|
Brite |
Drug groups [BR:br08330]
Antidiabetic agent
DG01685 Insulin sensitizer
DG01795 PPAR gamma agonist
DG01732 Non-thiazolidinedione type PPAR agonist
D06647 Sodelglitazar
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Thyroid hormone like receptors
Peroxisome proliferator-activated receptor (PPAR)
NR1C (PPAR)
D06647 Sodelglitazar (USAN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 33
1 C8x C 17.0100 -21.7000
2 C8y C 17.0100 -23.1000
3 C8x C 18.2224 -23.8000
4 C8x C 19.4349 -23.1000
5 C8y C 19.4349 -21.7000
6 C8y C 18.2224 -21.0000
7 S2a S 15.7976 -23.8000
8 C1b C 14.6021 -23.1096
9 C8y C 13.4147 -23.7951
10 C1a C 18.2224 -19.6002
11 O2a O 20.6660 -20.9890
12 C1d C 21.8712 -21.6847
13 C6a C 23.0535 -21.0019
14 O6a O 24.2475 -21.6912
15 O6a O 23.0535 -19.6002
16 C1a C 21.1712 -22.8971
17 C1a C 22.5712 -22.8971
18 S2x S 12.0926 -23.4198
19 C8y C 11.3239 -24.5597
20 N5x N 12.1705 -25.6431
21 C8y C 13.4624 -25.1727
22 C1a C 14.6198 -25.9537
23 C8y C 9.9405 -24.5383
24 C8y C 9.2725 -23.3394
25 C8x C 7.8727 -23.3180
26 C8y C 7.1543 -24.5196
27 C8x C 7.8222 -25.7185
28 C8x C 9.2221 -25.6699
29 X F 9.9952 -22.1312
30 C1d C 5.7400 -24.4982
31 X F 5.7400 -23.0982
32 X F 4.3400 -24.4982
33 X F 5.7400 -25.8982
BOND 35
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 2 7 1
8 7 8 1
9 8 9 1
10 6 10 1
11 5 11 1
12 11 12 1
13 12 13 1
14 13 14 1
15 13 15 2
16 12 16 1
17 12 17 1
18 9 18 1
19 18 19 1
20 19 20 2
21 20 21 1
22 9 21 2
23 21 22 1
24 19 23 1
25 23 24 2
26 24 25 1
27 25 26 2
28 26 27 1
29 27 28 2
30 23 28 1
31 24 29 1
32 26 30 1
33 30 31 1
34 30 32 1
35 30 33 1
|